Vanguard Health Care ETF(VHT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VHT Vanguard Health Care ETF

盘前交易 06-09 08:06:47 EDT

283.32

-0.81

-0.29%

盘前284.31

+0.99+0.35%

08:05 EDT

最高286.50	最低282.95	成交量39.97万
今开284.31	昨收284.13	日振幅1.25%
总市值167.80亿	流通市值167.80亿	总股本5,923万
成交额1.14亿	换手率0.67%	流通股本5,923万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"VHT","market":"US","secType":"STK","nameCN":"Vanguard Health Care ETF","latestPrice":283.32,"timestamp":1780948800000,"preClose":284.13,"halted":0,"volume":399695,"hourTrading":{"tag":"盘前","latestPrice":284.31,"preClose":283.32,"latestTime":"08:05 EDT","volume":29,"amount":8224.48236,"timestamp":1781006720159,"change":0.99,"changeRate":0.003494,"amplitude":0.01561},"delay":0,"changeRate":-0.0028508077288565176,"floatShares":59227656,"shares":59227656,"eps":9.211173,"marketStatus":"盘前交易","change":-0.81,"latestTime":"06-09 08:06:47 EDT","open":284.31,"high":286.5,"low":282.945,"amount":113912783.22265,"amplitude":0.012512,"askPrice":311.4,"askSize":40,"bidPrice":283.32,"bidSize":40,"shortable":3,"etf":1,"ttmEps":9.211173,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781011800000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":283.32,"sharesOutstanding":59747167,"nav":284.12,"aum":16845398655.84,"dividendRate":0.0166,"bidAskSpread":0.000397,"preHourTrading":{"tag":"盘前","latestPrice":284.31,"preClose":283.32,"latestTime":"08:05 EDT","volume":29,"amount":8224.48236,"timestamp":1781006720159,"change":0.99,"changeRate":0.003494,"amplitude":0.01561},"postHourTrading":{"tag":"盘后","latestPrice":283.32,"preClose":283.32,"latestTime":"19:58 EDT","volume":77,"amount":21802.1112,"timestamp":1780963115042,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.4376700885299547,"impliedVol":0.1707,"impliedVolPercentile":0.768},"requestUrl":"/m/hq/s/VHT","defaultTab":"news","newsList":[{"id":"2641161560","title":"欧洲股市反弹 医疗保健板块领涨 渣打和汇丰等英国银行股下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2641161560","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641161560?lang=zh_cn&edition=full","pubTime":"2026-06-05 01:42","pubTimestamp":1780594920,"startTime":"0","endTime":"0","summary":"欧洲股市周四反弹，医疗保健股上涨，Abivax SA和Zealand Pharma A/S涨幅居前。　　斯托克欧洲600指数收盘上涨0.5%，摆脱早盘跌势。医疗保健、金融服务和零售板块领涨，矿业股和电信股表现最差。　　Abivax大涨18%，此前该股因一项关键临床试验中的癌症病例而暴跌。　　欧洲股市今年以来上涨逾5%，但仍落后于美国和亚洲市场的涨势，后两者对AI主题的敞口更大。这导致瑞银集团的一篮子AI赢家股票下跌1.6%，不过该篮子今年以来仍上涨逾40%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-05/doc-iniahnxk9041101.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0310800965.SGD","LU2236285917.USD","LABU","BK1572","SG9999000327.SGD","VGK","BK1601","BK4534","HSBH","LU0496365809.HKD","VHT","BK1619","LU0149534421.HKD","BK4588","FEZ","SPEU","LU0211326755.USD","BK1231","LU0211326839.USD","SG9999001689.USD","FLEE","HSBC","LU0128525689.USD","02888","IEUR","LU0607220059.USD","STAN.UK","BK4207","VEA","BK4585","LU1267930227.SGD","IEV","BK4521","LU0211977185.USD","LU0052756011.USD","IEFA","BK4581","03143","EPV","BK4550","BK4504","XLV","XBI","EURL","LU0976567544.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639648130","title":"金元顺安医疗健康混合A基金经理变动：增聘韩辰尧为基金经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2639648130","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639648130?lang=zh_cn&edition=full","pubTime":"2026-05-29 09:53","pubTimestamp":1780019637,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年5月29日，金元顺安医疗健康混合发布公告，增聘韩辰尧为基金经理，任职日期自2026年5月29日起，陈铭杰不再担任该基金基金经理，离任日期为2026年5月29日，变更后金元顺安医疗健康混合的基金经理为张海东,韩辰尧。2022年05月加入金元顺安基金管理有限公司。2023年3月1日任金元顺安成长动力灵活配置混合型证券投资基金、金元顺安价值增长混合型证券投资基金基金经理。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202605/29/20260529636636.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202605/29/20260529636636.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260529/32263775.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK4581","IXJ","BK4550","159760","XLV","BK4588","LABU","XBI","VHT","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638353496","title":"Labcorp将出席Jefferies全球医疗保健大会","url":"https://stock-news.laohu8.com/highlight/detail?id=2638353496","media":"环球市场播报","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638353496?lang=zh_cn&edition=full","pubTime":"2026-05-28 04:00","pubTimestamp":1779912036,"startTime":"0","endTime":"0","summary":"全球领先的综合实验室服务提供商Labcorp Holdings Inc．今日宣布，公司将出席2026年Jefferies全球医疗保健大会并发表演讲。会议将于6月3日在纽约举行，公司演讲定于美国东部时间下午12时15分开始。　　Labcorp是一家业务覆盖约100个国家、拥有近71，000名员工的全球实验室服务巨头，为全球患者每年进行数亿次检测。　　根据公司2026年第一季度财报，Labcorp业绩表现强劲。　　本次会议演讲将通过网络直播，投资者可通过Labcorp投资者关系网站访问。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-28/doc-inhzksma8866144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["XBI","BK4550","BK4585","XLV","BK4588","BK4581","VHT","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638638727","title":"AngioDynamics将出席高盛第47届全球医疗保健年会","url":"https://stock-news.laohu8.com/highlight/detail?id=2638638727","media":"环球市场播报","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638638727?lang=zh_cn&edition=full","pubTime":"2026-05-28 03:02","pubTimestamp":1779908523,"startTime":"0","endTime":"0","summary":"医疗技术公司AngioDynamics今日宣布，公司管理团队将出席高盛第47届全球医疗保健年会并发表演讲。会议将于2026年6月10日举行，公司演讲定于美国东部时间上午9时20分开始。　　AngioDynamics是一家专注于恢复人体血管系统健康血流、拓展癌症治疗方案并改善患者生活质量的变革性医疗技术公司。其中医疗技术业务净销售额为3730万美元，同比增长19.0%，Auryon销售额增长17.9%，血栓管理业务增长17.9%，NanoKnife销售额增长21.0%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-28/doc-inhzknce0518623.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["BK4552","LABU","LU0096364046.USD","LU2471134796.USD","LU0251142724.SGD","VHT","LU1894683264.USD","BK4504","LU1791807156.HKD","LU2237438978.USD","GS","LU2237443382.USD","BK4588","LU2750360641.GBP","BK4550","IE0034235188.USD","LU0106831901.USD","LU1868837136.USD","LU0942090050.USD","LU2471134879.HKD","LU0345770308.USD","BK4585","LU0251131958.USD","IE00BSNM7G36.USD","LU2237443895.HKD","BK4533","LU1894683348.USD","GSX","LU1668664300.SGD","IE00BFXG1179.USD","LU2237443549.SGD","IE00B19Z3581.USD","LU0061475181.USD","LU1868836757.USD","LU0048573561.USD","LU0742534661.SGD","BK4581","LU0868494617.USD","LU1868836591.USD","IE0002270589.USD","IE00B19Z3B42.SGD","LU2471134952.CNY","LU2237443465.HKD","LU2237443978.SGD","LU1868836914.USD","XBI","LU0345770993.USD","BK4516","LU1868837300.USD","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638681039","title":"核心III期数据进入倒计时，Vistagen将出席Jefferies全球医疗保健年会","url":"https://stock-news.laohu8.com/highlight/detail?id=2638681039","media":"环球市场播报","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638681039?lang=zh_cn&edition=full","pubTime":"2026-05-27 23:28","pubTimestamp":1779895680,"startTime":"0","endTime":"0","summary":"专注于开发新型鼻内给药神经科学药物的Vistagen宣布，公司将出席于2026年6月2日至4日在纽约举行的Jefferies全球医疗保健年会。会议期间，公司管理层将与机构投资者进行一对一交流，介绍其创新的pherine候选药物管线的最新进展。　　Vistagen的先导候选药物fasedienol正处于美国注册导向的III期临床开发阶段，用于社交焦虑症的急性治疗。Vistagen认为，若其中任何一项III期试验成功，连同PALISADE-2的积极结果，可能构成提交新药上市申请所需的有效性实质证据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-27/doc-inhzkfve8244142.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","III","XBI","LABU","BK4581","BK4134","BK4550","VHT","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638896436","title":"临床阶段RNAi疗法公司Silence Therapeutics将出席Jefferies全球医疗保健年会","url":"https://stock-news.laohu8.com/highlight/detail?id=2638896436","media":"环球市场播报","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638896436?lang=zh_cn&edition=full","pubTime":"2026-05-27 22:37","pubTimestamp":1779892620,"startTime":"0","endTime":"0","summary":"临床阶段RNAi疗法公司Silence Therapeutics近日宣布，公司管理层将出席2026年6月3日下午4：55举行的Jefferies全球医疗保健年会，并进行分析师主导的炉边谈话。投资者可通过公司官网投资者关系页面收听现场网络直播，回放将在会议结束后提供。　　Silence Therapeutics目前最受关注的资产是divesiran，一种靶向TMPRSS6的siRNA疗法，用于治疗真性红细胞增多症。　　Silence Therapeutics总部位于伦敦，在纳斯达克以“SLN”代码交易，员工约88人。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-27/doc-inhzkfvc1451718.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4581","LENZ","XLV","BK4585","VHT","BK4588","XBI","BK4007","BK4550","LABU","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638968964","title":"临床阶段肿瘤生物技术公司Immunome将出席高盛第47届全球医疗保健年会","url":"https://stock-news.laohu8.com/highlight/detail?id=2638968964","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638968964?lang=zh_cn&edition=full","pubTime":"2026-05-27 22:31","pubTimestamp":1779892260,"startTime":"0","endTime":"0","summary":"临床阶段肿瘤生物技术公司Immunome5月27日宣布，公司管理层将出席2026年6月9日举行的高盛第47届全球医疗保健年会，并进行公司演讲。演讲定于当日上午10：40进行。投资者可通过公司官网投资者关系页面收听现场网络直播，并在直播结束后约30天内回看会议重播。　　Immunome目前最受关注的核心资产是varegacestat，一种正在研究的γ分泌酶抑制剂，用于治疗成人硬纤维瘤。　　截至2026年3月31日，Immunome持有现金及现金等价物约5.827亿美元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-27/doc-inhzkfvh9050122.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE0004091025.USD","LU0868494617.USD","LU1868836757.USD","BK4533","BK4127","LU0345770308.USD","LU0742534661.SGD","IE0002270589.USD","LU2237443465.HKD","LU2471134796.USD","BK4552","LU2237443382.USD","LU2750360997.AUD","LU2471134879.HKD","LU2471134523.USD","VHT","XLV","LU0251131958.USD","LU1668664300.SGD","BK4516","XBI","LU0251142724.SGD","LU1868837136.USD","LU2265009873.SGD","LU1868836914.USD","LU0061475181.USD","LU2237438978.USD","BK4588","LU2237443622.USD","LU0048573561.USD","LU1868836591.USD","GSX","BK4504","LU1894683348.USD","LU2471134952.CNY","LABU","LU2237443549.SGD","LU2237443978.SGD","LU1804176565.USD","BK4585","LU0106831901.USD","LU0096364046.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","LU0868494708.USD","LU1894683264.USD","LU2237443895.HKD","BK4550","IE0004086264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638545982","title":"DocGo将出席高盛第47届全球医疗保健年会","url":"https://stock-news.laohu8.com/highlight/detail?id=2638545982","media":"环球市场播报","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638545982?lang=zh_cn&edition=full","pubTime":"2026-05-26 23:07","pubTimestamp":1779808020,"startTime":"0","endTime":"0","summary":"移动医疗及医疗运输服务提供商DocGo Inc．今日宣布，公司首席执行官李·比恩斯托克将出席高盛第47届全球医疗保健年会，并参与炉边谈话。本次活动将通过DocGO官网投资者关系频道提供网络直播。　　DocGo是一家领先的移动医疗服务商，通过其创新的移动医疗平台、远程患者监测、救护车服务及覆盖全美50州的虚拟护理网络，重塑传统的实体医疗系统。　　此外，DocGo于今年3月启动的战略选择评估仍在进行中，公司将适时披露最新进展。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-26/doc-inhzfwqh8894225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["GS","LU1894683264.USD","IE00B19Z3B42.SGD","LU0096364046.USD","LU1868836591.USD","IE0002270589.USD","LU1668664300.SGD","LU2471134523.USD","LU0868494708.USD","LU0345770308.USD","LU2750360997.AUD","LU2237443465.HKD","IE00B19Z3581.USD","BK4504","LU1804176565.USD","LU2237443895.HKD","LU0868494617.USD","LU1868837136.USD","LU2471134796.USD","LU1894683348.USD","LU2750360641.GBP","BK4581","LU0942090050.USD","LU1868836757.USD","LU0106831901.USD","LU2471134952.CNY","LU2237443978.SGD","LU2237443622.USD","LABU","BK4552","LU2237443382.USD","IE00BFXG1179.USD","BK4516","IE00BSNM7G36.USD","LU0251131958.USD","XBI","BK4533","LU0048573561.USD","VHT","BK4588","LU0061475181.USD","LU2237438978.USD","XLV","LU2471134879.HKD","LU0251142724.SGD","IE0004091025.USD","IE0004086264.USD","LU0345770993.USD","IE0034235188.USD","GSX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636847240","title":"Scholar Rock将出席杰富瑞全球医疗保健大会，聚焦SMA新药apitegromab关键审批","url":"https://stock-news.laohu8.com/highlight/detail?id=2636847240","media":"环球市场播报","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636847240?lang=zh_cn&edition=full","pubTime":"2026-05-20 20:55","pubTimestamp":1779281725,"startTime":"0","endTime":"0","summary":"Scholar Rock公司宣布，管理层将于2026年6月3日上午11：40在纽约出席杰富瑞全球医疗保健大会并进行炉边谈话。此次活动正值公司核心药物apitegromab处于FDA审批的关键窗口期，备受投资者关注。　　根据公司公告，Scholar Rock董事长兼首席执行官David Hallal将代表公司出席此次大会。　　Scholar Rock的核心资产apitegromab是一种首创的肌肉靶向单克隆抗体，用于治疗脊髓性肌萎缩症。　　Scholar Rock正在将apitegromab的开发拓展至2岁以下婴幼儿SMA患者，其名为OPAL的2期试验正在持续入组和给药。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-20/doc-inhyqcsh9578240.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["BK4588","XLV","BK4585","SMA","BK4127","JEF","BK4550","VHT","LABU","XBI","BK4581","BK4217","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634427222","title":"中信证券医疗健康2025年报及2026年一季报总结：创新板块业绩集中兑现 内外共振推动行业质变开始","url":"https://stock-news.laohu8.com/highlight/detail?id=2634427222","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634427222?lang=zh_cn&edition=full","pubTime":"2026-05-11 08:38","pubTimestamp":1778459891,"startTime":"0","endTime":"0","summary":"2025年板块收入及扣非归母净利润增速分别为+2.77%、+5.76%;2026Q1板块营业收入及扣非归母净利润增速分别为+4.74%、+5.10%。头部Pharma业务结构从传统制药向创新药转变迅速，创新药放量逐步成为营收增长的核心驱动力。2025年Pharma板块的研发费用率为13.47%，相比2024年提升4.55个百分点;2026Q1，板块的研发费用率为13.03%，相比于2025Q1提升4.11个百分点。2025年板块收入增速约27.8%，继续保持较快增长趋势。创新药出海：中国创新药全球价值不断验证，料2026年进入密集数据催化期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439972.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600030","BK4588","LU1064131003.USD","LU1655091616.SGD","XLV","LU0405327494.USD","LABU","LU1794554557.SGD","LU1997244956.HKD","LU2289578879.USD","IXJ","BK1147","06030","159760","LU1781817850.SGD","BK4585","BK1564","LU1997245177.USD","BK0183","LU1328615791.USD","LU1997245094.SGD","XBI","LU1580142542.USD","BK0188","LU2495084118.USD","VHT","BK4550","LU1255011170.USD","BK0276","LU1720050803.USD","BK1521","BK0196","LU1064130708.USD","BK4581","BK0028","LU2148510915.USD","BK1516","LU0405327148.USD","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633170905","title":"新股消息 | 从招股书看好医生云医疗：AI驱动的医疗健康科技平台轮廓初现","url":"https://stock-news.laohu8.com/highlight/detail?id=2633170905","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633170905?lang=zh_cn&edition=full","pubTime":"2026-05-06 13:45","pubTimestamp":1778046321,"startTime":"0","endTime":"0","summary":"不过，招股书并未单独披露AI业务收入规模。从招股书来看，好医生云医疗的平台边界，已经从早期的线上服务，延伸到多个基层医疗关键环节。从招股书可以确认，AI好医生诊疗支持系统截至2026年4月6日已覆盖：29个省235个城市520多个县区，触达8500多家基层医疗机构，服务基层医生超过2.4万人，门诊数量超过3200万人次，生成病历超过2800万份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438413.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["XLV","LABU","BK4588","ARTY","159760","XBI","BK4581","AIPO","BK4585","IXJ","159891","BK4550","AGIX","CHAT","VHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633229968","title":"5月医疗保健股多空榜：Sensei及KalVista空头比例居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2633229968","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633229968?lang=zh_cn&edition=full","pubTime":"2026-05-05 03:24","pubTimestamp":1777922640,"startTime":"0","endTime":"0","summary":"随着4月结束，市值20亿美元以下的小型医疗保健股空头头寸显著增加，显示市场对这类高波动性股票的看空情绪升温。　　根据最新数据，5月初医疗保健板块空头比例最高的个股包括Sensei Biotherapeutics、KalVista Pharmaceuticals和GlucoTrack。　　在空头比例较低的个股中，Beyond Air和Polaryx Therapeutics名列前茅。　　值得注意的是，表格中提及的Sensei Biotherapeutics和KalVista Pharmaceuticals均在搜索报告的5月3日数据中列为高位空头标的。投资者需警惕这类高做空比例股票可能面临的逼空风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-05/doc-inhwunrr3304552.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XBI","BK4585","BK4550","XLV","LABU","BK4588","VHT","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629890197","title":"前高盛合伙人李逸斌出任摩根大通(JPM.US)全球医疗保健投行业务联席主管","url":"https://stock-news.laohu8.com/highlight/detail?id=2629890197","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629890197?lang=zh_cn&edition=full","pubTime":"2026-04-24 14:45","pubTimestamp":1777013116,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据媒体报道，摩根大通 任命Jerry Lee李逸斌、Nick Richitt为全球医疗保健投资银行联席主管。Jerry Lee，刚于今年第一季度加入摩根大通，此前他在高盛工作逾19年，他于2020年便晋升为高盛合伙人，离开高盛前担任全球生物医药投行业务和医疗保健投行业务主管，职业生涯中已为逾3000亿美元的已宣布并购交易提供过咨询。Jerry Lee，1999年获耶鲁大学学士学位、2007年获宾夕法尼亚大学沃顿商学院MBA学位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433281.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4207","XBI","LU1267930490.SGD","LU2054465674.USD","LU0215105999.USD","LU1868836914.USD","LU2552382132.HKD","VHT","LU0310799852.SGD","LU1720051017.SGD","XLV","LU2756315318.SGD","JPMO","LU1145028129.USD","LU0859254822.USD","LU2746668461.USD","LU0061475181.USD","LU2430703178.SGD","GSX","LU0203347892.USD","LU0265550359.USD","LU1548497426.USD","IE00BDRTCR15.USD","BK4504","LU2023250504.SGD","LU2592432038.USD","IE0034235295.USD","LU0345769631.USD","LU1064131342.USD","LU1917777945.USD","LU0640476718.USD","LU0976567544.SGD","LU2237443622.USD","LU1366192091.USD","LU1363072403.SGD","LU0256863811.USD","IE00BDCRKT87.USD","LU0345770993.USD","LABU","BK4533","BK4534","LU0203345920.USD","IE00BN8TJ469.HKD","LU1551013425.SGD","LU2237438978.USD","LU2237443549.SGD","LU2750360997.AUD","JPO","LU1868836757.USD","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629930310","title":"葛兰旗下中欧医疗健康混合一季报：药明康德(603259.SH)位列第一大重仓股 二季度看好创新产业链","url":"https://stock-news.laohu8.com/highlight/detail?id=2629930310","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629930310?lang=zh_cn&edition=full","pubTime":"2026-04-22 10:52","pubTimestamp":1776826345,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，4月22日，中欧基金披露葛兰和赵磊共同管理的中欧医疗健康混合型证券投资基金2026年第1季度报告。葛兰表示，一季度基于长期价值投资思路，继续重点关注创新药械及其产业链、消费医疗等领域。调仓换股方面，与2025年第4季度相比，中欧医疗健康混合在一季度减仓了康龙化成、泰格医药等个股，增持了凯莱英、信立泰、海思科、科伦药业，而艾力斯新进持仓前十。创新药及产业链预计将延续高景气度，是二季度重点关注方向。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1431729.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0708995583.HKD","IXJ","BK1141","XBI","LU0348766576.USD","02359","LU2328871848.SGD","LU2045819591.USD","LU0320764599.SGD","BK1583","LU2488822045.USD","LU0348767384.USD","BK1576","BK4550","BK4581","LU1969619763.USD","LU0052750758.USD","BK4588","LU1934453819.USD","LU1997245094.SGD","LU2495084118.USD","LU1997245177.USD","BK4585","XLV","BK0216","LU1979443071.USD","LU1808992512.USD","LU1997244956.HKD","159760","VHT","LU0456842615.SGD","LABU","LU2125910500.SGD","603259","LU2242644610.SGD","LU1046422090.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628240719","title":"中信证券：药价形成机制迎来大调整 医疗健康产业政策改革进入密集期","url":"https://stock-news.laohu8.com/highlight/detail?id=2628240719","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628240719?lang=zh_cn&edition=full","pubTime":"2026-04-17 08:12","pubTimestamp":1776384738,"startTime":"0","endTime":"0","summary":"医疗健康产业政策改革进入密集期，建议持续关注政策驱动下的医疗健康产业投资机会。中信证券主要观点如下：事件：4月14日，国务院办公厅印发《关于健全药品价格形成机制的若干意见》，15日国务院政策例行吹风会介绍健全全周期全渠道药品价格形成机制有关情况。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1429712.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0196","LU1997244956.HKD","LU1064130708.USD","BK0183","LU2495084118.USD","BK1147","LU1255011170.USD","BK0028","BK1516","LU0405327148.USD","BK4588","BK4550","BK0276","BK1521","BK0012","LU0405327494.USD","LU1794554557.SGD","LU1997245177.USD","IXJ","600030","BK0188","LU2289578879.USD","159760","VHT","LU2148510915.USD","LU1655091616.SGD","LABU","BK4585","LU1064131003.USD","LU1580142542.USD","06030","XLV","BK4581","LU1328615791.USD","BK1564","LU1781817850.SGD","LU1997245094.SGD","XBI","LU1720050803.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624567801","title":"葛兰旗下中欧医疗健康基金年报来袭！重仓股持续聚焦创新药产业链","url":"https://stock-news.laohu8.com/highlight/detail?id=2624567801","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624567801?lang=zh_cn&edition=full","pubTime":"2026-04-01 14:28","pubTimestamp":1775024920,"startTime":"0","endTime":"0","summary":"以其管理规模最大的中欧医疗健康为例，截至2025年年末，该基金的前十大重仓股与隐形重仓股未发生个股的更迭，报告期内持续聚焦创新药械及其产业链、OTC 及消费医疗等核心领域。葛兰表示，2026年继续看好创新药产业链，同时关注医疗器械国产替代与出海、消费医疗的困境反转。从最新披露的年报数据来看，中欧医疗健康的隐形重仓股同样未发生个股的更迭，均为以往持仓中原有的标的。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423860.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VHT","XBI","BK4585","IXJ","BK1574","BK1161","06978","BK4550","XLV","159760","LABU","159992","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622213879","title":"险企春招忙 AI和医疗健康类人才需求增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2622213879","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622213879?lang=zh_cn&edition=full","pubTime":"2026-03-28 00:08","pubTimestamp":1774627680,"startTime":"0","endTime":"0","summary":"随着“金三银四”招聘季的来临，中国人保、中国平安、新华保险、泰康保险、阳光保险、众安保险等多家险企密集发布2026年春季招聘信息。从岗位需求看，AI（人工智能）、大数据、技术开发等科技类人才以及医疗养老类人才的需求大幅增长。例如，中国平安集团表示，将携手旗下10余家成员公司，面向全球高校开展超3000个校招岗位、1500个实习生岗位的招聘。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603283687541778.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4581","BK4585","VHT","BK4588","159760","XBI","BK4550","AIPO","CHAT","IXJ","LABU","XLV","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622599288","title":"广州：拓展智能机器人在工业制造、家庭服务、医疗健康等领域的应用","url":"https://stock-news.laohu8.com/highlight/detail?id=2622599288","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622599288?lang=zh_cn&edition=full","pubTime":"2026-03-26 18:00","pubTimestamp":1774519200,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ （来源：界面新闻）广州市人民政府办公厅印发广州市促进人工智能产业高质量发展实施方案。其中提出，重点推动智能网联汽车、智能无人系统、全屋智能终端、智能可穿戴设备、工业智能终端、脑机接口等智能硬件产品的研发推广，推动车载端侧大模型应用，支持开发家电—中控—传感器协同的AIoT系统。推动具身智能机器人商业化，支持企业自主研发核心零部件，拓展智能机器人在工业制造、家庭服务、医疗健康等领域的应用。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/t/2026-03-26/doc-inhsikaq0160355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LABU","XBI","ROBO","BK4588","159760","XLV","IXJ","BK4585","BK4581","BK4550","VHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622846858","title":"印孚瑟斯拟收购两家美国咨询公司，以加强医疗保健和保险技术产品组合","url":"https://stock-news.laohu8.com/highlight/detail?id=2622846858","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622846858?lang=zh_cn&edition=full","pubTime":"2026-03-26 10:08","pubTimestamp":1774490887,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0164881194.USD","LU0862451753.SGD","LU1804176565.USD","IE00B3M56506.USD","IE00B0JY6M65.USD","LU0231203729.USD","LU0536402901.SGD","LU0333810181.USD","LU0831103253.SGD","LU1508157978.USD","BK4533","LU0348744763.USD","LU0708995666.HKD","LU1366334578.USD","LU1323998911.USD","IE00B7N09G41.SGD","BK4535","LU2663582299.SGD","LU0890818403.SGD","INFY","LU0868486357.SGD","LU2265009873.SGD","LABU","VHT","LU1267930656.SGD","XLV","LU0791591158.USD","LU0197229882.USD","LU0066902890.USD","BK4550","LU1102505762.USD","LU1805238398.USD","LU2087589342.USD","LU0791590937.USD","BK4523","BK4585","XBI","BK4134","BK4581","LU0898667661.SGD","LU0431992006.USD","LU0531971678.HKD","BK4588","IE00BYTNYM70.SGD","LU1366334651.USD","LU0287143357.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0253},{"period":"1month","weight":0.0533},{"period":"3month","weight":-0.0006},{"period":"6month","weight":-0.005},{"period":"1year","weight":0.1439},{"period":"ytd","weight":-0.0157}],"compareEarnings":[{"period":"1week","weight":-0.0255},{"period":"1month","weight":0.0022},{"period":"3month","weight":0.0916},{"period":"6month","weight":0.0751},{"period":"1year","weight":0.2338},{"period":"ytd","weight":0.084}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.008213},{"month":2,"riseRate":0.608696,"avgChangeRate":0.001185},{"month":3,"riseRate":0.521739,"avgChangeRate":0.002895},{"month":4,"riseRate":0.608696,"avgChangeRate":0.010267},{"month":5,"riseRate":0.695652,"avgChangeRate":0.006434},{"month":6,"riseRate":0.695652,"avgChangeRate":0.008419},{"month":7,"riseRate":0.727273,"avgChangeRate":0.019444},{"month":8,"riseRate":0.590909,"avgChangeRate":0.005271},{"month":9,"riseRate":0.409091,"avgChangeRate":-0.004416},{"month":10,"riseRate":0.5,"avgChangeRate":-0.000221},{"month":11,"riseRate":0.818182,"avgChangeRate":0.026667},{"month":12,"riseRate":0.545455,"avgChangeRate":0.003563}],"exchange":"ARCA","name":"Vanguard Health Care ETF","nameEN":"Vanguard Health Care ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Vanguard Health Care ETF(VHT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Vanguard Health Care ETF(VHT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Vanguard Health Care ETF,VHT,Vanguard Health Care ETF股票,Vanguard Health Care ETF股票老虎,Vanguard Health Care ETF股票老虎国际,Vanguard Health Care ETF行情,Vanguard Health Care ETF股票行情,Vanguard Health Care ETF股价,Vanguard Health Care ETF股市,Vanguard Health Care ETF股票价格,Vanguard Health Care ETF股票交易,Vanguard Health Care ETF股票购买,Vanguard Health Care ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Vanguard Health Care ETF(VHT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Vanguard Health Care ETF(VHT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}